InstellingenIk ga akkoord



Orphan Drugs resubmission date - ($ 1,600,000)

The FDA Office of Orphan Products Development's (OOPD) invites applications for its Orphan Products Grants Program. The resubmission due date is October 15, 2013. The goal of the program is to encourage clinical development of products for use in rare diseases or conditions. The products studied can be drugs, biologics, medical devices, or medical foods. Grants are up to $ 400,000 per year for up to 4 years.

Terug naar overzicht